133 related articles for article (PubMed ID: 18159211)
1. Intraocular rituximab.
Singh AD; Peereboom DM
Eye (Lond); 2007 Dec; 21(12):1453-4. PubMed ID: 18159211
[No Abstract] [Full Text] [Related]
2. Intraocular use of rituximab.
Kitzmann AS; Pulido JS; Mohney BG; Baratz KH; Grube T; Marler RJ; Donaldson MJ; O'Neill BP; Johnston PB; Johnson KM; Dixon LE; Salomao DR; Cameron JD
Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
[TBL] [Abstract][Full Text] [Related]
3. In focus: ECOG 4402: Rituximab Extended Schedule or Retreatment Trial (RESORT).
Clin Adv Hematol Oncol; 2004 Mar; 2(3):152. PubMed ID: 16166942
[No Abstract] [Full Text] [Related]
4. Rituximab for intraocular lymphoma.
Itty S; Pulido JS
Retina; 2009 Feb; 29(2):129-32. PubMed ID: 19202422
[No Abstract] [Full Text] [Related]
5. ECOG 4402: randomized phase III-trial comparing two different rituximab dosing regimens for patients with low tumor burden indolent non-Hodgkin's lymphoma.
Williams ME
Curr Hematol Rep; 2004 Nov; 3(6):395-6. PubMed ID: 15496271
[No Abstract] [Full Text] [Related]
6. [Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin's lymphoma].
Fernández Cañabate E; Fernández-Cañabate S
Farm Hosp; 2018 Jan; 42(1):20-21. PubMed ID: 29306309
[TBL] [Abstract][Full Text] [Related]
7. Rituxan: the new kid on the block.
Jonas C
Oncol Nurs Forum; 1998 May; 25(4):669. PubMed ID: 9599347
[No Abstract] [Full Text] [Related]
8. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy.
Itty S; Olson JH; O'Connell DJ; Pulido JS
Retina; 2009 Mar; 29(3):415-6. PubMed ID: 19174721
[No Abstract] [Full Text] [Related]
9. Intra-CSF rituximab for lymhomatous meningitis.
Chamberlain MC; Glantz MJ
J Clin Oncol; 2007 Oct; 25(28):4508-9; author reply 4509-11. PubMed ID: 17906219
[No Abstract] [Full Text] [Related]
10. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.
Rubenstein JL; Fridlyand J; Abrey L; Shen A; Karch J; Wang E; Issa S; Damon L; Prados M; McDermott M; O'Brien J; Haqq C; Shuman M
J Clin Oncol; 2007 Apr; 25(11):1350-6. PubMed ID: 17312328
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of rituximab and its clinical use: thought for the best use?
Cartron G; Blasco H; Paintaud G; Watier H; Le Guellec C
Crit Rev Oncol Hematol; 2007 Apr; 62(1):43-52. PubMed ID: 17287129
[TBL] [Abstract][Full Text] [Related]
12. Clinical review: treatment of vitreoretinal lymphoma.
Pe'er J; Hochberg FH; Foster CS
Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma.
Ohguro N; Hashida N; Tano Y
Arch Ophthalmol; 2008 Jul; 126(7):1002-3. PubMed ID: 18625954
[No Abstract] [Full Text] [Related]
14. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
15. Rituximab in primary conjunctiva lymphoma.
Zinzani PL; Alinari L; Stefoni V; Loffredo A; Pichierri P; Polito E
Leuk Res; 2005 Jan; 29(1):107-8. PubMed ID: 15541482
[TBL] [Abstract][Full Text] [Related]
16. Rapid infusion rituximab changing practice for patient care.
Al Zahrani A; Ibrahim N; Al Eid A
J Oncol Pharm Pract; 2009 Sep; 15(3):183-6. PubMed ID: 19171551
[TBL] [Abstract][Full Text] [Related]
17. Edema of the eyelids and sclera after rituximab infusion for orbital MALT lymphoma.
Oribe N; Tanimoto TE; Shimoda K; Hikiji W; Mitsugi K; Takase K; Henzan H; Numata A; Miyamoto T; Fukuda T; Nagafuji K; Harada M
Haematologica; 2004 Jun; 89(6 Suppl):EIM14. PubMed ID: 15194556
[No Abstract] [Full Text] [Related]
18. Interaction between statins and rituximab in non-Hodgkin's lymphoma.
Rabinowitz I
J Clin Oncol; 2008 Nov; 26(33):5486; author reply 5486. PubMed ID: 18936467
[No Abstract] [Full Text] [Related]
19. The pharmacokinetics of rituximab following an intravitreal injection.
Kim H; Csaky KG; Chan CC; Bungay PM; Lutz RJ; Dedrick RL; Yuan P; Rosenberg J; Grillo-Lopez AJ; Wilson WH; Robinson MR
Exp Eye Res; 2006 May; 82(5):760-6. PubMed ID: 16289160
[TBL] [Abstract][Full Text] [Related]
20. Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.
Landgren O; Dunleavy K; Wilson WH
J Natl Cancer Inst; 2009 Sep; 101(18):1287-8; author reply 1289-90. PubMed ID: 19687413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
